 Shares of Nu Skin Enterprises Inc. NUS, 2.50 dropped 3.6 toward a 15-month low in premarket trading Monday, after the personal care products company warned of a revenue miss, saying the delta variant has led to unexpected COVID-related disruptions. The company said it estimates third-quarter revenue of 637 million to 642 million, below the FactSet consensus of 710 million. 